2-Chlorodeoxyadenosine treatment in the Sezary syndrome
- PMID: 9028972
2-Chlorodeoxyadenosine treatment in the Sezary syndrome
Comment on
-
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.Blood. 1996 Feb 1;87(3):906-11. Blood. 1996. PMID: 8562961 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
